CLINICAL_TRIALS
trial_result
· 2017-10-13
Clinical Trial Update: The Contact-CTI Study: Use of Tissue Contact Data to Guide Atrial Flutter Ablation [Phase 4]
Summary
The Contact-CTI study evaluated using tissue contact data to guide atrial flutter ablation in a Phase 4 trial, which has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Oxford University Hospitals NHS Trust | Conditions: Atrial Flutter | Phase 4 | Status: COMPLETED